Merging Antibody Developability with De Novo Design
Time: 3:00 pm
day: Day Two
Details:
- Exploring the interplay between structure and sequence-based biologics design
- Implementing machine learning tools for structure-based de novo design
- Highlighting the data challenges that limit this
